Revvity Inc (RVTY)
124.82
+3.78
(+3.12%)
USD |
NYSE |
Nov 04, 16:00
124.76
-0.06
(-0.05%)
Pre-Market: 20:00
Revvity Research and Development Expense (TTM): 201.13M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 201.13M |
| March 31, 2024 | 210.25M |
| December 31, 2023 | 216.58M |
| September 30, 2023 | 221.52M |
| June 30, 2023 | 222.00M |
| March 31, 2023 | 220.78M |
| December 31, 2022 | 221.62M |
| September 30, 2022 | 227.66M |
| June 30, 2022 | 223.56M |
| March 31, 2022 | 233.35M |
| December 31, 2021 | 236.04M |
| September 30, 2021 | 173.34M |
| June 30, 2021 | 174.05M |
| March 31, 2021 | 157.74M |
| December 31, 2020 | 146.44M |
| September 30, 2020 | 196.20M |
| June 30, 2020 | 191.45M |
| March 31, 2020 | 190.27M |
| December 31, 2019 | 189.34M |
| September 30, 2019 | 193.67M |
| June 30, 2019 | 197.14M |
| March 31, 2019 | 195.99M |
| December 31, 2018 | 194.00M |
| September 30, 2018 | 179.76M |
| June 30, 2018 | 165.80M |
| Date | Value |
|---|---|
| March 31, 2018 | 152.16M |
| December 31, 2017 | 139.46M |
| September 30, 2017 | 134.56M |
| June 30, 2017 | 129.19M |
| March 31, 2017 | 127.50M |
| December 31, 2016 | 124.18M |
| September 30, 2016 | 107.99M |
| June 30, 2016 | 109.58M |
| March 31, 2016 | 110.39M |
| December 31, 2015 | 112.54M |
| September 30, 2015 | 113.78M |
| June 30, 2015 | 113.13M |
| March 31, 2015 | 110.80M |
| December 31, 2014 | 108.06M |
| September 30, 2014 | 122.76M |
| June 30, 2014 | 123.73M |
| March 31, 2014 | 127.78M |
| December 31, 2013 | 132.58M |
| September 30, 2013 | 132.72M |
| June 30, 2013 | 133.72M |
| March 31, 2013 | 133.39M |
| December 31, 2012 | 131.84M |
| September 30, 2012 | 130.60M |
| June 30, 2012 | 128.30M |
| March 31, 2012 | 122.26M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
146.44M
Minimum
Dec 2020
236.04M
Maximum
Dec 2021
202.81M
Average
210.25M
Median
Mar 2024
Research and Development Expense (TTM) Benchmarks
| Bionano Genomics Inc | 42.10M |
| Avantor Inc | -- |
| Bruker Corp | 328.80M |
| Azenta Inc | 34.04M |
| Harvard Bioscience Inc | 11.42M |